FDA
approval
· 2022-05-27
FDA Approved: LEVETIRACETAM — Original Application (ScieGen Pharmaceuticals, Inc.)
Summary
The FDA approved an original Abbreviated New Drug Application (ANDA) for Levetiracetam from ScieGen Pharmaceuticals, establishing a generic version of the antis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LEVETIRACETAM (LEVETIRACETAM)